Binovi Technologies Past Earnings Performance
Past criteria checks 0/6
Binovi Technologies's earnings have been declining at an average annual rate of -23%, while the Healthcare Services industry saw earnings growing at 1.8% annually. Revenues have been growing at an average rate of 29.6% per year.
Key information
-23.0%
Earnings growth rate
33.1%
EPS growth rate
Healthcare Services Industry Growth | -3.9% |
Revenue growth rate | 29.6% |
Return on equity | -78.0% |
Net Margin | -1,794.9% |
Last Earnings Update | 30 Nov 2021 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Binovi Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Nov 21 | 0 | -8 | 5 | 0 |
31 Aug 21 | 1 | -9 | 6 | 0 |
31 May 21 | 1 | -9 | 6 | 0 |
28 Feb 21 | 1 | -9 | 7 | 0 |
30 Nov 20 | 1 | -9 | 7 | 0 |
31 Aug 20 | 1 | -8 | 6 | 1 |
31 May 20 | 1 | -8 | 5 | 0 |
29 Feb 20 | 1 | -8 | 5 | 0 |
30 Nov 19 | 1 | -5 | 3 | 0 |
31 Aug 19 | 1 | -5 | 3 | 0 |
31 May 19 | 1 | -5 | 4 | 1 |
28 Feb 19 | 1 | -5 | 4 | 0 |
30 Nov 18 | 1 | -5 | 4 | 1 |
31 Aug 18 | 0 | -5 | 4 | 1 |
31 May 18 | 0 | -4 | 3 | 0 |
28 Feb 18 | 0 | -3 | 2 | 0 |
30 Nov 17 | 0 | -3 | 3 | 0 |
31 Aug 17 | 0 | -3 | 3 | 0 |
31 May 17 | 0 | -3 | 3 | 0 |
28 Feb 17 | 0 | -4 | 4 | 0 |
30 Nov 16 | 0 | -4 | 3 | 0 |
31 Aug 16 | 0 | -4 | 3 | 1 |
31 May 16 | 0 | -5 | 4 | 1 |
29 Feb 16 | 0 | -4 | 3 | 1 |
30 Nov 15 | 0 | -3 | 2 | 1 |
Quality Earnings: VISN is currently unprofitable.
Growing Profit Margin: VISN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VISN is unprofitable, and losses have increased over the past 5 years at a rate of 23% per year.
Accelerating Growth: Unable to compare VISN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VISN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (41.2%).
Return on Equity
High ROE: VISN has a negative Return on Equity (-78.02%), as it is currently unprofitable.